Inventor
PARK TAE SUN
KR20 patents
⚠️ This page may combine multiple inventors who share the name “PARK TAE SUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV YONSEI IACF
9 patentsUS10137070B2Nov 27, 2018
Composition including ionone or salt thereof as active ingredient and having effect of enhancing skin moisturizing, exfoliating skin, improving skin elasticity, inhibiting erythema, improving skin wrinkles, or alleviating skin photoaging
UNIV YONSEI IACF2 citations71
US11904038B2Feb 20, 2024
Composition for preventing hair loss or promoting hair development, comprising phellandrene as active ingredient
UNIV YONSEI IACF0 citations61
US11576875B2Feb 14, 2023
Composition comprising ethyl vanillin as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression
UNIV YONSEI IACF0 citations61
US11246813B2Feb 15, 2022
Composition for preventing hair loss or promoting hair development, comprising irone as active ingredient
UNIV YONSEI IACF0 citations61
US11096917B2Aug 24, 2021
Composition for preventing or treating muscle diseases, comprising suberic acid or pharmaceutically acceptable salt thereof as active ingredient
UNIV YONSEI IACF0 citations61
US11096903B2Aug 24, 2021
Use of pinocarveol
UNIV YONSEI IACF0 citations61
US10617612B2Apr 14, 2020
Composition comprising decanal or as active ingredients for preventing hair loss or stimulating hair growth
UNIV YONSEI IACF0 citations50
US10100011B2Oct 16, 2018
Pentadienoyl piperidine derivative and use thereof
UNIV YONSEI IACF0 citations50
US9321751B2Apr 26, 2016
Piperine derivatives and uses thereof
UNIV YONSEI IACF0 citations30
PARK TAE SUN
8 patentsUS8946283B2Feb 3, 2015
Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
PARK TAE SUN2 citations60
US8552069B2Oct 8, 2013
Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient
PARK TAE SUN3 citations60
US10167507B2Jan 1, 2019
Metabolic diseases-related odorant receptor genes and use thereof
PARK TAE SUN0 citations50
US9884041B2Feb 6, 2018
Composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient
PARK TAE SUN0 citations50
US9040557B2May 26, 2015
Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
PARK TAE SUN0 citations50
US8741964B2Jun 3, 2014
Uses of nonenal
PARK TAE SUN0 citations50
US8614250B2Dec 24, 2013
Uses of adipic acid
PARK TAE SUN1 citations50
US8828954B2Sep 9, 2014
Use for scopolin and derivatives thereof
PARK TAE SUN0 citations42